文献速递流行病学与生物统计

终末与非终末事件竞争风险下临床试验疗效的检验与估计

Testing and Estimation of Treatment Effects in Clinical Trials for Terminal and Nonterminal Events Subject to Competing Risks.
PubMed 文献 · Stat Med · 2025-01-01

针对临床试验中非终末事件与终末事件并存且受竞争风险影响的情形,本文综述了近年发展的多种分析方法,指出传统首次事件分析置信区间较宽且检验效能不足,并在更一般的竞争风险框架下提出新的非参数检验与估计方法,建立其渐近有效性,并用一项近期大规模临床试验进行展示。

要点

  • 传统首次事件分析未充分利用非终末事件与终末事件数据,置信区间相对较宽、检验效能较低。
  • 近年多种方法各有侧重,部分方法难以用原因别风险解释,存在解释困难与强假设要求。
  • 本文在更一般的竞争风险设定下提出新的非参数检验与估计方法并确立渐近有效性。

核心结论

  • 本文提出新的非参数检验与估计方法处理终末与非终末事件的竞争风险,并建立其渐近有效性。

研究设计与样本

  • 方法学文章,综述近年发展的多种方法并在比文献更一般的竞争风险设定下提出新方法,用一项近期大规模临床试验进行展示。

主要发现

  • 传统首次事件分析(如对数秩检验和Cox比例风险回归)未能充分利用可用数据,导致置信区间相对较宽且检验效能较低。
  • 近年提出的方法中,部分涉及复杂模型,部分具直观吸引力但含隐藏条件,且各方法针对特定科学问题。
  • 部分近期方法不能通过原因别风险处理竞争风险,可能导致解释困难、需要强假设和推广性较差。

局限性

  • 传统首次事件分析未能充分利用可用数据,导致置信区间相对较宽且检验效能较低。
  • 部分近期方法不能通过原因别风险处理竞争风险,可能导致解释困难、需要强假设和推广性较差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In clinical trials, multiple outcomes are often of interest. For time-to-event outcomes, it is the norm rather than exception that one or more nonterminal events (e.g., heart failure hospitalization) and a terminal event (e.g., cardiovascular death) are encountered, subject to competing risks in addition to independent censoring. In this setting, traditionally, time-to-first event analysis is used to assess treatment effect, with popular procedures such as the log-rank test and the Cox proportional hazards regression. However, this approach fails to fully utilize available data, resulting in relatively wide confidence intervals and less powerful tests. Various methods have been proposed in recent years, some involving complex models and others having intuitive appeal but hidden conditions. Furthermore, each method was motivated to address specific scientific questions. Navigating this landscape can be challenging for users. In addition, although competing risks can often be accommodated by considering cause-specific hazards, that is not the case for some of the recently proposed methods, which may lead to difficulty in interpretation, requirement of strong assumptions, and less generalizability. This article provides a brief summary of several recently developed methods, discussing the strengths and limitations of each approach. Then, the problem is framed in a more general setup than in the literature for a wider range of competing risks scenarios. Furthermore, new nonparametric testing and estimation procedures are proposed, and their asymptotic validity is established. The methods are illustrated in a recent large scale clinical trial.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Yang S. Testing and Estimation of Treatment Effects in Clinical Trials for Terminal and Nonterminal Events Subject to Competing Risks. Stat Med. 2025. PMID: 40844866. doi:10.1002/sim.70205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。